Glutathione promotes the synergistic effects of venetoclax and azacytidine against myelodysplastic syndrome‑refractory anemia by regulating the cell cycle-Reference-Cited by-同舟云学术

Glutathione promotes the synergistic effects of venetoclax and azacytidine against myelodysplastic syndrome‑refractory anemia by regulating the cell cycle

Published:2023-10-26 Issue:6 Volume:26 Page:
ISSN:1792-0981
Container-title:Experimental and Therapeutic Medicine
language:
Short-container-title:Exp Ther Med

Author:

Wang Xiaobo¹,Yuan Lihua²,Lu Bo¹,Lin Dongjun¹,Xu Xiaojun¹

Affiliation:

1. Department of Hematology, The Seventh Affiliated Hospital, Sun Yat‑Sen University, Shenzhen, Guangdong 518107, P.R. China

2. Department of Pediatric Surgery, University of Hong Kong‑Shenzhen Hospital, Shenzhen, Guangdong 518000, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Immunology and Microbiology (miscellaneous),General Medicine

Reference75 articles.

1. Myelodysplastic Syndromes: A new decade;Volpe;Clin Lymphoma Myeloma Leuk,2022

2. Myelodysplastic syndromes: 2018 update on diagnosis, risk-stratification and management;Montalban-Bravo;Am J Hematol,2018

3. Guadecitabine (SGI-110): An investigational drug for the treatment of myelodysplastic syndrome and acute myeloid leukemia;Daher-Reyes;Expert Opin Investig Drugs,2019

4. The safety and efficacy of rigosertib in the treatment of myelodysplastic syndromes;Navada;Expert Rev Anticancer Ther,2016

5. PD-1 signaling and inhibition in AML and MDS;Haroun;Ann Hematol,2017

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Venetoclax: a new player in the treatment of children with high-risk myeloid malignancies?;Blood Advances;2024-07-09